Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPPOL · Entity 4061 | Director | March 31, 2017 | April 04, 2017 |
| Celanese CorpCE · Entity 3922 | Director | March 09, 2017 | March 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date March 31, 2017 · Filed April 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDeferred Comp Plan | 17,803 |
Reported balance
After 2017-03-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-03-31 · Grant · Acquired 842 · Balance 17,803 F1: Includes 65 shares acquired on January 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | Direct | 148,444 |
Reported balance
Holding disclosure · report date 2017-03-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 148,444 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 65 shares acquired on January 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.
Celanese Corp
Report date March 09, 2017 · Filed March 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Common StockSEC Table I · non-derivative | Direct | 38,961 |
Ending reported balance
After 2017-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-03-09 · Exercise / conversion · Acquired 3,925.54 · Balance 38,961.54 F1: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. Row 2 · 2017-03-09 · Disposition to issuer · Disposed 0.54 · Balance 38,961 |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 6,081.243 |
Reported balance
After 2017-03-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-03-09 · Exercise / conversion · Disposed 3,925.54 · Balance 6,081.243 F1: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2017 Filed Apr 4, 2017 20:23 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 842 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013914 · form4.xml · nonDerivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 17,803 F1 · balance_after: Includes 65 shares acquired on January 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 16:37 UTC | Celanese Corp CE · Entity 3922 | Exercise / conversionPhantom Stock · Derivative | 3,925.54 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-17-000100 · wf-form4_148943743181998.xml · derivative · entry 3 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,081.243 Underlying: Series A Common Stock · 3,925.54 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. F1 · price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. F1 · derivative.exercise_date: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. F1 · derivative.expiration_date: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 16:37 UTC | Celanese Corp CE · Entity 3922 | Disposition to issuerSeries A Common Stock | 0.54 | $89.06 | $48.09 |
DisclosureSEC source: 0001306830-17-000100 · wf-form4_148943743181998.xml · nonDerivative · entry 2 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,961 Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 16:37 UTC | Celanese Corp CE · Entity 3922 | Exercise / conversionSeries A Common Stock | 3,925.54 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-17-000100 · wf-form4_148943743181998.xml · nonDerivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,961.54 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. The shares of phantom stock are payable in shares of Series A common Stock, as provided in the Company's 2008 Deferred Compensation Plan (the "Plan"), on the earlier of the date previously elected by the reporting person to receive payment or the termination of such person's service as a director of the Company. The reported phantom stock transaction represents annual grants of resticted stock units, including dividend equivalents, which were previously deferred under the Plan. On March 9, 2017, 3,925 of the reporting person's shares of phantom stock were settled for an equal number of shares of the Company's Series A Common Stock, and 0.54 shares of phantom stock were settled for cash in lieu of fractional shares. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:57 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 39.872 | $89.99 | $3,588.08 |
DisclosureSEC source: 0001306830-17-000088 · wf-form4_148892382986593.xml · derivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,006.783 Underlying: Series A Common Stock · 39.872 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 21:58 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 890 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-000257 · form4.xml · nonDerivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 16,896 F1 · ownership.nature: A distribution of 60,867 shares was made from the Deferred Compensation Plan for Nonemployee Directors (the "Director Plan") on November 1, 2008. This distribution is reflected by a decrease of 60,867 shares in the Director Plan balance and an increase of 60,867 in the direct holdings in this report. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:53 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 46.811 | $76.29 | $3,571.21 |
DisclosureSEC source: 0001306830-16-000438 · wf-form4_147916397986290.xml · derivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,966.911 Underlying: Series A Common Stock · 46.811 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:37 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063723 · form4.xml · nonDerivative · entry 1 WALTERS FARAH M · CIK 0001189424 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 15,953 F1 · balance_after: Includes 47 shares acquired on July 8, 2016 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.